New strategies in the treatment of early Parkinson's diseaseRINNE, U. K.Acta neurologica Scandinavica. Supplementum. 1991, Vol 84, Num 136, pp 95-98, issn 0065-1427Article

Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-upRINNE, U. K.Neurology. 1987, Vol 37, Num 5, pp 826-828, issn 0028-3878Article

Early combination of dopamine agonist and levodopa in the treatment of Parkinson's diseaseRINNE, U. K.The Mount Sinai journal of medicine. 1988, Vol 55, Num 2, pp 138-141, issn 0027-2507Article

Combined bromocriptine-levodopa therapy early in Parkinson's diseaseRINNE, U. K.Neurology. 1985, Vol 35, Num 8, pp 1196-1198, issn 0028-3878Article

Combination of a dopamine agonist, MAO-B inhibitor and levodopa ― a new strategy in the treatment of early Parkinson's diseaseRINNE, U. K.Acta neurologica Scandinavica. Supplementum. 1989, Vol 80, Num 126, pp 165-169, issn 0065-1427, 5 p.Article

Lisuride, a dopamine agonist in the treatment of early Parkinson's diseaseRINNE, U. K.Neurology. 1989, Vol 39, Num 3, pp 336-339, issn 0028-3878Article

Strategies in the treatment of early Parkinson's diseaseRINNE, U. K.Acta neurologica Scandinavica. Supplementum. 1993, Vol 87, Num 146, pp 50-53, issn 0065-1427Conference Paper

Function of dopamine receptors in Parkinson's disease: prolactin responsesLAIHINEN, A; RINNE, U. K.Neurology. 1986, Vol 36, Num 3, pp 393-395, issn 0028-3878Article

A new approach to the treatment of Parkinson's disease, symposium, Turku, May 27, 1983RINNE, U. K.Acta neurologica Scandinavica. Supplementum. 1983, Vol 68, Num 95, issn 0065-1427, 144 p.Conference Proceedings

A double-blind pharmacokinetic and clinical dose-response study of entacapone as an adjuvant to levodopa therapy in advanced Parkinson's diseaseRUOTTINEN, H. M; RINNE, U. K.Clinical neuropharmacology. 1996, Vol 19, Num 4, pp 283-296, issn 0362-5664Article

Selegiline in the treatment of Parkinson's diseaseHEINONEN, E. H; RINNE, U. K.Acta neurologica Scandinavica. Supplementum. 1989, Vol 80, Num 126, pp 103-111, issn 0065-1427, 9 p.Article

Entacapone prolongs levodopa response in a one month double blind study in parkinsonian patients with levodopa related fluctuationsRUOTTINEN, H. M; RINNE, U. K.Journal of neurology, neurosurgery and psychiatry. 1996, Vol 60, Num 1, pp 36-40, issn 0022-3050Conference Paper

A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's diseaseOLANOW, C. W.Movement disorders. 1993, Vol 8, pp S1-S7, issn 0885-3185, SUP1Conference Paper

Progression and survival in Parkinson's diseaseMARTTILA, R. J; RINNE, U. K.Acta neurologica Scandinavica. Supplementum. 1991, Vol 84, Num 136, pp 24-28, issn 0065-1427Article

Treatment of early Parkinson's disease with controlled-release levodopa preparationsRINNE, U. K; RINNE, J. O.Neurology. 1990, Vol 39, Num 11, pp 78-81, issn 0028-3878, 4 p., SUPLT2Conference Paper

New strategies in the treatment of Parkinson's disease, Copenhagen, Denmark, January 26-27, 1989RINNE, U. K; PAKKENBERG, H; JENSEN, N.-O et al.Acta neurologica Scandinavica. Supplementum. 1989, Vol 80, Num 126, issn 0065-1427, 219 p.Conference Proceedings

Alcohol consumption of patients with essential tremorRAUTAKORPI, I; MARTTILA, R. J; RINNE, U. K et al.Acta neurologica scandinavica. 1983, Vol 68, Num 3, pp 177-179, issn 0001-6314Article

Oxygen toxicity protecting enzymes in Parkinson's disease: increase of superoxide dismutase-like activity in the substantia nigra and basal nucleusMARTTILA, R. J; LORENTZ, H; RINNE, U. K et al.Journal of the neurological sciences. 1988, Vol 86, Num 2-3, pp 321-331, issn 0022-510XArticle

Effect of one month's treatment with peripherally acting catechol-O-methyltransferase inhibitor, entacapone, on pharmacokinetics and motor response to levodopa in advanced Parkinsonian patientsRUOTTINEN, H. M; RINNE, U. K.Clinical neuropharmacology. 1996, Vol 19, Num 3, pp 222-233, issn 0362-5664Article

Selegiline can mediate neuronal rescue rather than neuronal protectionTATTON, W. G.Movement disorders. 1993, Vol 8, pp S20-S30, issn 0885-3185, SUP1Conference Paper

Neurotoxins and monoamine oxidase inhibition: new aspectsFINNEGAN, K. T.Movement disorders. 1993, Vol 8, pp S14-S19, issn 0885-3185, SUP1Conference Paper

Nigral degeneration in Parkinson's diseaseRINNE, J. O.Movement disorders. 1993, Vol 8, pp S31-S35, issn 0885-3185, SUP1Conference Paper

Comparison of lisuride and bromocriptine in the treatment of advanced Parkinson's diseaseLAIHINEN, A; RINNE, U. K; SUCHY, I et al.Acta neurologica scandinavica. 1992, Vol 86, Num 6, pp 593-595, issn 0001-6314Article

Epidemiological approaches to the etiology of Parkinson's diseaseMARTTILA, R. J; RINNE, U. K.Acta neurologica Scandinavica. Supplementum. 1989, Vol 80, Num 126, pp 13-18, issn 0065-1427, 6 p.Article

Parkinson's disease and essential tumor in families of patients with early-onset Parkinson's diseaseMARTTILA, R. J; RINNE, U. K.Journal of neurology, neurosurgery and psychiatry. 1988, Vol 51, Num 3, pp 429-431, issn 0022-3050Article